<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04292366</url>
  </required_header>
  <id_info>
    <org_study_id>participationCRC2020</org_study_id>
    <nct_id>NCT04292366</nct_id>
  </id_info>
  <brief_title>Optimising Colorectal Cancer Screening Participation</brief_title>
  <official_title>Optimising Colorectal Cancer Screening Participation -A Randomised Controlled Trial of Invitation Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to demonstrate the effectiveness of three and four-staged invitation
      procedures compared to two-staged procedures by combining pre-notifications and reminders.
      The RCT will be nested into the Danish colorectal cancer screening programme in the Central
      Denmark Region including men and women aged 50-74 years. Participants will consecutively be
      randomized into four arms in a 1:1 ratio. Intervention arm 1 will receive a pre-notification
      approximately ten days prior to intervention, invitation and one reminder (three-staged
      intervention), Intervention arm 2 will receive invitation, one reminder after 45 days and a
      second reminder three months after invitation (three-staged invitation procedure),
      Intervention arm 3 will receive pre-notification, invitation, reminder after 45 days and
      reminder after three months (four-staged invitation procedure). Finally, the forth arm will
      be a control group receiving usual care which invitation and one reminder 45 days after
      invitation (two-staged invitation procedure). Both pre-notifications and reminders are sent
      using digital mail.

      The main out-come will be participation within 6 months after invitation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 2, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Participation</measure>
    <time_frame>Within six months after invitaiton</time_frame>
    <description>Participation in colorectal cancer screening</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">48000</enrollment>
  <condition>Colorectal Neoplasms</condition>
  <arm_group>
    <arm_group_label>Intervention arm I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>pre-notification approximately ten days prior to intervention, invitation and one reminder (three-staged intervention)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention arm II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>invitation, one reminder after 45 days and a second reminder three months after invitation (three-staged invitation procedure)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention arm III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>pre-notification, invitation, reminder after 45 days and reminder after three months (four-staged invitation procedure)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>invitation and one reminder after 45 days (usual care)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Invitation procedure</intervention_name>
    <description>Optimised invitation procedures in an organised colorectal cancer screening programme</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Intervention arm I</arm_group_label>
    <arm_group_label>Intervention arm II</arm_group_label>
    <arm_group_label>Intervention arm III</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Invited for colorectal cancer screening

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mette Bach Larsen, PhD</last_name>
    <phone>+4578420265</phone>
    <email>metbacla@rm.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Randers Regional Hospital</name>
      <address>
        <city>Randers</city>
        <zip>8930</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mette Bach Larsen, PhD</last_name>
      <phone>+4578420265</phone>
      <email>metbacla@rm.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 27, 2020</study_first_submitted>
  <study_first_submitted_qc>February 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2020</study_first_posted>
  <last_update_submitted>February 27, 2020</last_update_submitted>
  <last_update_submitted_qc>February 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mass screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

